Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $6.8200 (2.17%) ($6.8200 - $6.8200) on Tue. Aug. 23, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.04% (three month average) | RSI | 62 | Latest Price | $6.8200(2.17%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -2.6% a day on average for past five trading days. | Weekly Trend | TGTX advances 1.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XLK(96%) SPY(90%) XLC(90%) XBI(89%) ARKG(83%) | Factors Impacting TGTX price | TGTX will decline at least -3.52% in a week (0% probabilities). USO(-20%) OIH(22%) URA(45%) UUP(-54%) TBT(-24%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.52% (StdDev 7.04%) | Hourly BBV | 0.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $6.98 | 5 Day Moving Average | $7.04(-3.13%) | 10 Day Moving Average | $7.49(-8.95%) | 20 Day Moving Average | $6.98(-2.29%) | To recent high | -19% | To recent low | 82.6% | Market Cap | $864m | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |